{"disease":{"id":"metastatic-breast-cancer-with-brca-1-or-brca-2-genetic-mutation","name":"metastatic breast cancer with brca 1 or brca 2 genetic mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02985658","title":"Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Washington","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}